510(k) K140691
K140691 is an FDA 510(k) premarket notification submitted by Sqi Diagnostics Systems, Inc. for the device "IG_PLEX CELIAC DGP PANEL". The FDA issued a decision of Substantially Equivalent on Nov 6, 2014. The device falls under product code MVM (Autoantibodies, Endomysial(Tissue Transglutaminase)), a Class II device regulated under 21 CFR 866.5660. Sqi Diagnostics Systems, Inc. has 2 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Nov 6, 2014
- Date Received
- Mar 19, 2014
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Autoantibodies, Endomysial(Tissue Transglutaminase)
- Device Class
- Class II
- Regulation Number
- 866.5660
- Review Panel
- IM
- Submission Type
- 510(k)
Need the full FDA record for Sqi Diagnostics Systems, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.